Covestor’s Zymeworks ZYME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$0 Sell
15
-25
-63% -$648 ﹤0.01% 2910
2026
Q2
$1K Buy
40
+12
+43% +$305 ﹤0.01% 2401
2026
Q1
$1K Sell
28
-26
-48% -$615 ﹤0.01% 2181
2025
Q4
$1K Buy
54
+1
+2% +$22 ﹤0.01% 2204
2025
Q3
$1K Buy
53
+27
+104% +$386 ﹤0.01% 2211
2025
Q2
$0 Sell
26
-1
-4% -$12 ﹤0.01% 2832
2025
Q1
$0 Hold
27
– – ﹤0.01% 2803
2024
Q4
$0 Buy
27
+9
+50% +$126 ﹤0.01% 2821
2024
Q3
$0 Sell
18
-23
-56% -$250 ﹤0.01% 2850
2024
Q2
$0 Sell
41
-97
-70% -$863 ﹤0.01% 2839
2024
Q1
$1K Buy
+138
New +$1.53K ﹤0.01% 2151

Other funds holding ZYME

Covestor's ZYME Position: Q3 2026 in Review

Covestor reduced its Zymeworks (ZYME) stake by 63% in Q3 2026, selling an estimated $648 and leaving 15 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #2910.

Covestor first reported a position in ZYME in Q1 2024 and has held it in 11 quarters since. The position peaked at $1K in Q2 2026. 33 funds tracked by Wall St. Rank hold ZYME as of Q3 2026.

  • Covestor held 15 shares of Zymeworks worth $0 as of Q3 2026.
  • Covestor sold 25 Zymeworks shares in Q3 2026, an estimated $648.
  • Zymeworks made up ﹤0.01% of Covestor's portfolio in Q3 2026, its #2910 holding.
  • Covestor first reported a position in Zymeworks in Q1 2024 and has held it in 11 quarters since.
  • Covestor's Zymeworks position peaked at $1K in Q2 2026.
  • 33 funds tracked by Wall St. Rank held Zymeworks as of Q3 2026.

Based on Covestor's 13F filing for Q3 2026, filed 30 Oct 2026.